CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
Clinical trial NCT03152526 · TERMINATED
Trial details
- NCT number
- NCT03152526
- Sponsor
- Miltenyi Biotec B.V. & Co. KG
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2018-03-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.